Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 34 Records) |
Query Trace: Ovarian Neoplasms and ERCC1[original query] |
---|
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Nov 25 (33): 5172-9. Smith Stephanie, Su Dan, Rigault de la Longrais Irene A, Schwartz Peter, Puopolo Manuela, Rutherford Thomas J, Mor Gil, Yu Herbert, Katsaros Dionyssi |
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 0 18 (4): 702-10. Steffensen K D, Waldstrøm M, Jeppesen U, Brandslund I, Jakobsen |
Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. The pharmacogenomics journal 2010 Feb 10 (1): 54-61. Khrunin A V, Moisseev A, Gorbunova V, Limborska |
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecologic oncology 2009 May 113 (2): 264-9. Kim Hee Seung, Kim Mi-Kyung, Chung Hyun Hoon, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kang Soon Be |
Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer. Cancer 2012 Feb 118 (3): 689-97. Fleming Nicole D, Agadjanian Hasmik, Nassanian Hoorig, Miller Carl W, Orsulic Sandra, Karlan Beth Y, Walsh Christine |
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics 2011 Dec . Khrunin A, Ivanova F, Moisseev A, Khokhrin D, Sleptsova Y, Gorbunova V, Limborska S |
[Association of polymorphisms in glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population]. Genetika 2012 Jul 48 (7): 901-4. Khokhrin D V, Khrunin A V, Moiseev A A, Gorbunov V A, Limborskaia S |
Predictive value of excision repair cross-complementing rodent repair deficiency complementation group 1 and ovarian cancer risk. Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 1799-802. He Shan-Yang, Xu Lin, Niu Gang, Ke Pei-Qi, Feng Miao-Miao, Shen Hong-W |
Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecologic oncology 2012 Sep 126 (3): 448-54. Deloia Julie A, Bhagwat Nikhil R, Darcy Kathleen M, Strange Mary, Tian Chunquio, Nuttall Kevin, Krivak Thomas C, Niedernhofer Laura |
Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy. Pharmacogenomics 2012 Mar 13 (4): 419-27. Yan Li, Shu-Ying Yang, Shan Kang, Yip Benjamin H K, Rong-Miao Zhou, Na Wang, Hai-Yan S |
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study. Gynecologic oncology 2012 May 125 (2): 421-6. Rubatt Jennifer M, Darcy Kathleen M, Tian Chunqiao, Muggia Franco, Dhir Rajiv, Armstrong Deborah K, Bookman Michael A, Niedernhofer Laura J, Deloia Julie, Birrer Michael, Krivak Thomas Ca |
The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer. Gynecologic oncology 2013 Aug 130 (2): 377-82. Moxley K M, Benbrook D M, Queimado L, Zuna R E, Thompson D, McCumber M, Premkumar P, Thavathiru E, Hines L, Moore K |
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
Association of Rs11615 (C>T) in the excision repair cross-complementing group 1 gene with ovarian but not gynecological cancer susceptibility: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6071-4. Ma Yong-Jun, Feng Sheng-Chun, Hu Shao-Long, Zhuang Shun-Hong, Fu Guan-H |
Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2014 Mar 19 (2): 128-34. Li Yan, Hu Pei, Cao Yu, Wang Gui-ying, Wang Na, Zhou Rong-mi |
[Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy]. Zhonghua fu chan ke za zhi 2013 Nov 48 (11): 847-52. Qi Bing-li, Li Yan, Wang Na, Zhou Rong-miao, Hu Pei, Kang Sh |
Correlation of UGT1A1 and ERCC1 gene polymorphisms with the outcome of combined irinotecan plus cisplatin treatment in recurrent ovarian cancer. Genetics and molecular research : GMR 2015 14 (2): 7241-7. Xu Q, Ding Y Y, Song L X, Xu J |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis. BMC women's health 2017 Jun 17 (1): 43. Tang Ning, Lyu Dan, Zhang Yan, Liu Haipi |
Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer treatment reviews 2017 Dec 61 35-52. Assis Joana, Pereira Carina, Nogueira Augusto, Pereira Deolinda, Carreira Rafael, Medeiros R |
The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility. Bioscience reports 2018 Apr . Zhao Zhiguang, Zhang Anqi, Zhao Yuan, Xiang Junmiao, Yu Danyang, Liang Zongwen, Xu Chaoyi, Zhang Qiong, Li Jianmin, Duan Pi |
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies. Hereditary cancer in clinical practice 2019 7 17 21. Buckingham Lela, Mitchell Rachel, Maienschein-Cline Mark, Green Stefan, Hu Vincent Hong, Cobleigh Melody, Rotmensch Jacob, Burgess Kelly, Usha Lyd |
Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility. Journal of cellular biochemistry 2019 May . Yang Fan, Mu Xiyan, Bian Ce, Zhang Huan, Yi Tao, Zhao Xia, Lin Xiaoju |
ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 1925-1929. Liblab Salisa, Vusuratana Apichai, Areepium Nuttha |
Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort. International journal of immunogenetics 2020 3 47 (5): 443-453. Bao Yuxia, Yang Bin, Zhao Jingjiao, Shen Simin, Gao Jianyu |
MassArray analysis of genomic susceptibility variants in ovarian cancer. Scientific reports 2020 12 10 (1): 21101. Verma Sonali, Sharma Indu, Sharma Varun, Bhat Amrita, Shah Ruchi, Bhat Gh Rasool, Sharma Bhanu, Bakshi Divya, Nagpal Ashna, Wakhloo Ajay, Bhat Audesh, Kumar Rake |
ERCC1 expression and platinum chemosensitivity in patients with ovarian cancer: A meta-analysis. The International journal of biological markers 2020 10 35 (4): 12-19. Zhang Chunjie, Gao Shan, Hou Jingw |
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis. Journal of ovarian research 2021 Jun 14 (1): 80. Zhang Yuqiang, Cao Sufen, Zhuang Chunyu, Chen Jiacheng, Chen Xiaojing, Sun Hong, Lin Shengying, Lin Baila |
Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population. PloS one 2023 5 18 (5): e0284825. Xiaoqing Wu, Wenping Lu, Cuihong Jiang, Dongni Zhang, Weixuan Zhang, Yongjia Cui, Zhili Zhuo, Heting Mei, Ya'nan Wang, Mengfan Zhang, Shuntai Ch |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: